Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients

被引：51
|
作者：
Arima, Hidetoshi [1 ,2 ]
Motoyama, Keiichi [1 ]
Higashi, Taishi [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
[2] Kumamoto Univ, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Program Leading Grad Sch, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 2017年 / 65卷 / 04期
关键词：
cyclodextrin (CyD); drug delivery system (DDS); active pharmaceutical ingredient; non-viral vector; supramolecule; METHYL-BETA-CYCLODEXTRIN; TERNARY INCLUSION COMPLEX; SUSTAINED-RELEASE SYSTEM; PICK-C-DISEASE; IN-VITRO; ALPHA-CYCLODEXTRIN; PEGYLATED INSULIN; BIOCLEAVABLE POLYROTAXANES; FULMINANT-HEPATITIS; GAMMA-CYCLODEXTRINS;
D O I：
10.1248/cpb.c16-00779
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cyclodextrins (CyDs) are extensively used in various fields, and especially have been widely utilized as pharmaceutical excipients and drug carriers in the pharmaceutical field. Owing to the multi -functional and biocompatible characteristics, CyDs can improve the undesirable properties of drug molecules. This review outlines the current application of CyDs in pharmaceutical formulations, focusing on their use as CyD-based drug carriers for several kinds of drugs. Additionally, CyDs have great potential as active pharmaceutical ingredients against various diseases with few side effects.
引用
收藏
页码：341 / 348
页数：8
相关论文
共 50 条
  • [1] The Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short Overview
    di Cagno, Massimiliano Pio
    MOLECULES, 2017, 22 (01):
  • [2] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    ENVIRONMENTAL CHEMISTRY LETTERS, 2025, 23 (01) : 1 - 6
  • [3] Cyclodextrins as Drug Carriers in Pharmaceutical Technology: The State of the Art
    Conceicao, Jaime
    Adeoye, Oluwatomide
    Cabral-Marques, Helena Maria
    Sousa Lobo, Jose Manuel
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (13) : 1405 - 1433
  • [4] Pharmaceutical application of cyclodextrins as multi-functional drug carriers
    Uekama, K
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 (12): : 909 - 935
  • [5] Impurities in Drug Products and Active Pharmaceutical Ingredients
    Katny, M.
    Frankowski, M.
    CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY, 2017, 47 (03) : 187 - 193
  • [6] PHARMACEUTICAL CHEMICALS France invests in drug active ingredients
    Mccoy, Michael
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (25) : 15 - 15
  • [7] FDA inspections of drug products and active pharmaceutical ingredients
    Kirrstetter, R
    PHARMAZEUTISCHE INDUSTRIE, 2004, 66 (10): : 1260 - +
  • [8] Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis
    Yuki Maeda
    Keiichi Motoyama
    Taishi Higashi
    Yuka Horikoshi
    Toru Takeo
    Naomi Nakagata
    Yuki Kurauchi
    Hiroshi Katsuki
    Yuki Kondo
    Yoichi Ishitsuka
    Tetsumi Irie
    Takumi Erad
    Hidetoshi Arima
    Asian Journal of Pharmaceutical Sciences, 2016, 11 (01) : 183 - 184
  • [9] The role of degradant profiling in active pharmaceutical ingredients and drug products
    Alsante, Karen M.
    Ando, Akemi
    Brown, Roland
    Ensing, Janice
    Hatajik, Todd D.
    Kong, Wei
    Tsuda, Yoshiko
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) : 29 - 37
  • [10] Impurities in Active Pharmaceutical Ingredients and Drug Products: A Critical Review
    Cordeiro, Cleydson Finotti
    Franco, Lucas Lopardi
    Carvalho, Diogo Teixeira
    Bonfilio, Rudy
    CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY, 2024,
12345